Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 17Active not recruiting 5Terminated 3Recruiting 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 1

Conditions

Tobacco Use Cessation 1Smoking Cessation 1Hand-Foot Syndrome 1HIV Seropositivity 1Breast Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

Cyclophosphamide 391Carboplatin 344Gemcitabine 332pembrolizumab 331Cisplatin 328Paclitaxel 298Radiotherapy 297Docetaxel 287Bevacizumab 253Rituximab 234Capecitabine 224Nivolumab 222Dexamethasone 206Fluorouracil 190fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 134Cetuximab 130fludarabine phosphate 129Bortezomib 129Lenalidomide 126Filgrastim 120Erlotinib Hydrochloride 120Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Tobacco Use Cessation Devices × Clear all
NCT00751101 2020-10-05

Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer

University of California, San Francisco

Phase 2 Terminated
24 enrolled 12 charts
Breast

Breast Neoplasms, Hand-Foot Syndrome

NCT02302859 2020-01-27

Mobile Media-Rich Interactive Guideline System (MMRIGS) Pilot Study

M.D. Anderson Cancer Center

Phase NA Terminated
8 enrolled 3 charts

Acquired Immunodeficiency Syndrome, HIV Seropositivity, Tobacco Use Cessation

NCT00931021 2013-07-15

Smoking Cessation Treatment for Head and Neck Cancer Patients

Yale University

Phase EARLY_PHASE1 Terminated
7 enrolled

Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡